- Home
- DNN vs RCUS Comparison
DNN vs RCUS Comparison
Compare DNN & RCUS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- DNN
- RCUS
- Stock Information
- Founded
- DNN 1936
- RCUS 2015
- Country
- DNN Canada
- RCUS United States
- Employees
- DNN N/A
- RCUS N/A
- Industry
- DNN Other Metals and Minerals
- RCUS Biotechnology: Pharmaceutical Preparations
- Sector
- DNN Basic Materials
- RCUS Health Care
- Exchange
- DNN Nasdaq
- RCUS Nasdaq
- Market Cap
- DNN 1.3B
- RCUS 906.4M
- IPO Year
- DNN 1997
- RCUS 2018
- Fundamental
- Price
- DNN $1.85
- RCUS $9.52
- Analyst Decision
- DNN Strong Buy
- RCUS Buy
- Analyst Count
- DNN 2
- RCUS 9
- Target Price
- DNN $3.00
- RCUS $20.86
- AVG Volume (30 Days)
- DNN 143.1M
- RCUS 1.1M
- Earning Date
- DNN 08-07-2025
- RCUS 08-07-2025
- Dividend Yield
- DNN N/A
- RCUS N/A
- EPS Growth
- DNN N/A
- RCUS N/A
- EPS
- DNN N/A
- RCUS N/A
- Revenue
- DNN $3,176,679.00
- RCUS $141,000,000.00
- Revenue This Year
- DNN $288.69
- RCUS N/A
- Revenue Next Year
- DNN $22.40
- RCUS $28.73
- P/E Ratio
- DNN N/A
- RCUS N/A
- Revenue Growth
- DNN 24.45
- RCUS N/A
- 52 Week Low
- DNN $1.08
- RCUS $6.50
- 52 Week High
- DNN $2.47
- RCUS $18.98
- Technical
- Relative Strength Index (RSI)
- DNN 54.90
- RCUS 57.71
- Support Level
- DNN $1.67
- RCUS $8.03
- Resistance Level
- DNN $1.86
- RCUS $9.97
- Average True Range (ATR)
- DNN 0.09
- RCUS 0.47
- MACD
- DNN -0.01
- RCUS 0.11
- Stochastic Oscillator
- DNN 57.14
- RCUS 71.32
About DNN Denison Mines Corp (Canada)
Denison Mines Corp is a uranium exploration and development company focused on the Athabasca Basin region of northern Saskatchewan, Canada. The company holds a noteworthy 95% interest in its flagship Wheeler River Uranium Project, the undeveloped uranium project located in the infrastructure-rich eastern part of the Athabasca Basin. Additionally, it is involved in mine decommissioning and environmental services through its Closed Mines group, which manages the Elliot Lake reclamation projects and offers third-party post-closure mine care and maintenance services. The Company operates in two main segments: the Mining segment and the Corporate and Other segment. The majority of revenue is generated from the mining segment.
About RCUS Arcus Biosciences Inc.
Arcus Biosciences Inc is a clinical-stage biopharmaceutical company. It develops immunotherapies for the treatment of cancer. The company focuses on an ATP-adenosine pathway, which is a key driver of immunosuppression in the tumor microenvironment to create and optimize differentiated small-molecule immuno-oncology product candidates. Its product pipeline includes Domvanalimab, Etrumadenant, AB598, Casdatifan among others. Arcus conducts clinical trials for different types of cancers such as Lung, Colorectal, Pancreatic, and others. The company operates through a single segment which is the business of developing and commercializing immunotherapies.